Premium
Asenapine (Sycrest): sublingual antipsychotic for acute mania
Author(s) -
Chaplin Steve,
Smith Daniel
Publication year - 2012
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.942
Subject(s) - asenapine , medicine , antipsychotic , mania , bipolar disorder , adverse effect , psychiatry , atypical antipsychotic , pediatrics , schizophrenia (object oriented programming) , lithium (medication)
Asenapine (Sycrest) is an antipsychotic taken sub ‐ lingually for the treatment of moderate to severe manic episodes in bipolar disorder. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Daniel Smith discusses its place in therapy. Copyright © 2012 Wiley Interface Ltd